Hyman Charles D Pfizer Inc Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Pfizer Inc stock. As of the latest transaction made, Hyman Charles D holds 150,341 shares of PFE stock, worth $4.02 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

150,341

Previous 155,313 3.2%

Holding current value

$4.02 Million

Previous $4.31 Million 2.39%

% of portfolio

0.23%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $125,592 - $147,171	-4,972 Reduced 3.2%	150,341 $4.21 Million
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $88,725 - $101,884	3,427 Added 2.26%	155,313 $4.31 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $28,533 - $37,062	-1,092 Reduced 0.71%	151,886 $4.37 Million
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $29,554 - $34,546	-921 Reduced 0.6%	152,978 $5.07 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $1,805 - $2,089	-50 Reduced 0.03%	153,899 $5.65 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $23,634 - $30,768	-600 Reduced 0.39%	153,949 $6.28 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $192,368 - $234,834	-4,396 Reduced 2.77%	154,549 $6.76 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $63,839 - $75,693	-1,372 Reduced 0.86%	158,945 $8.33 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $155,550 - $192,746	3,400 Added 2.17%	160,317 $8.3 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $296,801 - $439,958	7,183 Added 4.8%	156,917 $9.27 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $11,343 - $14,571	-289 Reduced 0.19%	149,734 $6.44 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $73,076 - $82,783	-2,035 Reduced 1.34%	150,023 $5.88 Million
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $13,630 - $15,372	-407 Reduced 0.27%	152,058 $5.51 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $80,930 - $102,910	-2,418 Reduced 1.56%	152,465 $5.61 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $295,084 - $346,201	9,294 Added 6.38%	154,883 $5.68 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $586,376 - $711,360	19,468 Added 15.44%	145,589 $4.76 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $75,305 - $107,595	-2,786 Reduced 2.16%	126,121 $4.12 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $84,341 - $95,716	2,562 Added 2.03%	128,907 $5.05 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $71,120 - $92,222	-2,189 Reduced 1.7%	126,345 $4.54 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $25,738 - $28,897	696 Added 0.54%	128,534 $5.57 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $694,087 - $762,570	18,509 Added 16.93%	127,838 $5.43 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $79,209 - $90,307	-2,059 Reduced 1.85%	109,329 $4.77 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $18,234 - $22,117	529 Added 0.48%	111,388 $4.91 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $33,606 - $35,828	-1,019 Reduced 0.91%	110,859 $4.02 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $50,130 - $58,158	-1,571 Reduced 1.38%	111,878 $3.97 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $16,995 - $18,033	511 Added 0.45%	113,449 $4.11 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $257,145 - $283,274	-8,295 Reduced 6.84%	112,938 $4.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	121,233	121,233 $4.07 Million

Others Institutions Holding PFE

# of Institutions

3,267

Shares Held

3.73B

Call Options Held

74.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account